BLUMY yields 5.04% · PFE yields 6.13%● Live data
📍 BLUMY pulled ahead of the other in Year 1
Combined, BLUMY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BLUMY + PFE for your $10,000?
Blue Moon Group Holdings Limited engages in the research, design, development, manufacture, and sale of personal hygiene, home care, and fabric care products in China. It offers fabric care products, including machine wash laundry, pre-wash treatment, underwear laundry, hand wash, strain removers, and fabric softeners, as well as baby liquid laundry detergents; personal hygiene products comprising liquid soaps; toilet and bathroom cleaners; and general home care products, such as anti-mould cleansers, washing machine cleaners, floor cleaners, bleaches, glass cleaners, multi-surface cleaners, and rust cleaners; and antiseptic disinfectant liquids. The company also provides kitchen cleaning products, including utensil, fruit, and vegetable cleaning products, as well as range of hood cleaners. The company offers its products under the Blue Moon, Supreme, Jingxiang, and Tianlu brands. It sells its products through e-commerce platforms, online stores, hypermarkets, supermarkets, and offline distributors. The company was founded in 1992 and is headquartered in Guangzhou, China.
Full BLUMY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.